Navigation Links
AST 'Emergence to Convergence' Highlights the Latest High-Risk Organ Donor and Recipient Issues
Date:11/28/2007

2008 American Society of Transplantation Winter Symposium Kicks Off March

13

PALM SPRINGS, Calif., Nov. 28 /PRNewswire/ -- Organ transplantation is increasingly being offered to patients with multiple co-morbidities and to those at high risk for immune injury. In addition, the ongoing donor shortage has prompted the increasing use of donors with characteristics that increase the risk of allograft failure. On March 13-16, 2008, the American Society of Transplantation (AST) will host its 12th Annual Winter Symposium in Palm Springs, Calif. The meeting will focus on the key issues facing high-risk recipients and the issues related to using high-risk donors. Of particular importance are the sessions surrounding the consensus approaches to managing waiting lists, organ allocation, immunological desensitization, viral infection, protocol biopsies, malignancy and age-specific immunosuppression. Delivered by outstanding speakers, this excellent scientific program will be hosted in one of the nation's most luxurious vacation destinations, Ranchos Las Palmas Resort & Spa.

The Program

As the nation deals with recent news of four organ recipients being infected with HIV and hepatitis by a high-risk donor, Emily Blumberg MD, will address disclosure and testing issues during the Winter Symposium.

The AST 2008 Winter Symposium will put participants in touch with innovative research and development on a broad range of topics. The agenda will appeal to transplant professionals in a wide array of specialties with topics such as: Trials, Tribulations and Real Issues of Managing Wait Lists, Managing the Pediatric Recipient, Desensitization-The Latest, New Methods to Monitor Immunity, Managing the High-Risk Donor, Risks and Ethics in Transplantation and so much more! The scientific program will consolidate the transplant community's experience and outline future challenges to management consensus.

The Symposium has been designed to provide attendees consolidated knowledge and skills to understand current outcomes in solid organ transplantation relative to prior decades, to understand proposed new allocation rules in the United States, to recognize the ethical issues of transplantation in the current decade, and to formulate strategies to manage waiting lists, high-risk recipients and outcomes using high-risk donors.

New in 2008

In 2008, AST is proud to announce the inclusion of "Poster Pods." Attendees who participate in the abstract session of the Winter Symposium will be part of the newly added Poster Pods, which is a moderated poster session with audience and author interaction.

Accreditation

AST is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians and offers AMA PRA category 1 credits. Continuing education units for nurses and transplant coordinators are also available for this program.

To register or to receive more information, go to http://www.a-s-t.org.

Contact: Beth Drost at 215.884.6499


'/>"/>
SOURCE Accreditation Council for Continuing Medical Education
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Climatic variations influence the emergence of cholera in Africa
2. Stanford study highlights cost-effective method of lowering heart disease risks
3. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
4. Other highlights in the September 11 JNCI
5. NEWSWEEK International Editions: Highlights and Exclusives, Oct. 1, 2007 Issue
6. Georgia Pecans Fit!: New Campaign Highlights Health Benefits, Recipes, Web Site
7. Highlights from the October 2007 Journal of the American Dietetic Association
8. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
9. NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue
10. Study Highlights Impact of Chronic Conditions on Working America
11. Report highlights inadequate pandemic planning as a threat to EU security
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... ... Despite its pervasiveness, many physicians are unfamiliar with how best to treat ... practice. Now, however, a timely review has been published in the Journal of ... NeuP and educating preclinical scientists on its diagnosis and choice of treatment. , The ...
(Date:6/20/2017)... Murfreesboro, Tennessee (PRWEB) , ... June 20, 2017 ... ... chronic care services, announced today that Claritas Capital, a Nashville-based private equity firm, ... to accelerate our expansion plans for some time, and Claritas Capital offers the ...
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, Inc., ... a new eBook titled “ 5 Questions to Ask Before Entering the Maze ... the Genetic Test Evaluation (GTE) team, the book explores the various types of ...
(Date:6/20/2017)... ... 20, 2017 , ... AMC Health , the leading provider of proven ... trials market. Similar to its approach in demonstrating positive outcomes in the healthcare market, ... proving the value of eVisits to support virtual studies. , In a ...
(Date:6/20/2017)... ... June 20, 2017 , ... With certifications and experience that puts ... NJ, Drs. Adam and Hal Kimowitz are currently accepting new patients at their practice ... can cause for some patients, which is why they offer the latest in modern ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
(Date:6/2/2017)... Mass. , June 2, 2017  NxStage Medical, ... renal care, today announced new findings demonstrating positive biochemical ... ® System One™. The data will be presented ... in Madrid, Spain . ... to Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)... Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), a ... of stem cells, today provided a corporate update and ... 31 st , 2017. "We are ... of 2017," said Dr. Shai Yarkoni, Chief Executive Officer. ... the first blood cancer patient in the recently initiated ...
Breaking Medicine Technology: